BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $356,000 | -54.8% | 3,000 | -47.6% | 0.11% | -46.6% |
| Q4 2021 | $788,000 | -3.1% | 5,720 | -2.2% | 0.21% | -6.8% |
| Q3 2021 | $813,000 | +6.8% | 5,850 | -25.4% | 0.22% | +2.8% |
| Q2 2021 | $761,000 | +27.5% | 7,840 | -10.2% | 0.22% | +17.5% |
| Q1 2021 | $597,000 | -4.0% | 8,730 | +20.2% | 0.18% | -6.2% |
| Q4 2020 | $622,000 | +11.9% | 7,260 | -15.2% | 0.20% | -4.4% |
| Q3 2020 | $556,000 | +8.8% | 8,560 | +22.5% | 0.20% | +1.0% |
| Q2 2020 | $511,000 | – | 6,990 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |